Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1557421/000119312517262294/d432950d8k.htm
February 2018
December 2017
December 2017
November 2017
October 2017
October 2017
October 2017
September 2017
September 2017
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1557421/000119312517262294/d432950d8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ignyta, Inc..
Ignyta, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Ignyta, Inc. provided additional information to their SEC Filing as exhibits
CIK: 1557421Events:
Form Type: 8-K Corporate News
Accession Number: 0001193125-17-262294
Submitted to the SEC: Fri Aug 18 2017 4:46:36 PM EST
Accepted by the SEC: Fri Aug 18 2017
Period: Thursday, August 17, 2017
Industry: Pharmaceutical Preparations